These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis]. Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420 [TBL] [Abstract][Full Text] [Related]
3. [What is the role of autoimmune processes in nephropathies?]. Ehrich JH; Oemar BS; Bruijn JA Monatsschr Kinderheilkd; 1990 Nov; 138(11):724-9. PubMed ID: 2290431 [TBL] [Abstract][Full Text] [Related]
4. New advances in understanding the treatment of glomerulonephritis. Lockwood CM Clin Nephrol; 1986; 26 Suppl 1():S76-80. PubMed ID: 3829472 [TBL] [Abstract][Full Text] [Related]
6. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis]. Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510 [TBL] [Abstract][Full Text] [Related]
8. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043 [TBL] [Abstract][Full Text] [Related]
9. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis. Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099 [TBL] [Abstract][Full Text] [Related]
12. [The role of cellular immunity in the pathogenesis of glomerulonephritis]. Kacprzyk F; Orłowski Z Postepy Hig Med Dosw; 1989; 43(2-4):199-212. PubMed ID: 2702352 [TBL] [Abstract][Full Text] [Related]